Usage: Auryxia controls serum phosphorus levels in adult chronic kidney disease (CKD) patients on dialysis, and treats iron deficiency anemia in adult CKD patients not on dialysis.
Usage: Feraheme treats iron deficiency anemia (IDA) in adults who cannot tolerate oral iron, have not responded to oral iron, or have chronic kidney disease (CKD).
Usage: Injectafer treats iron deficiency anemia in adults and children 1+ year old with oral iron intolerance or inadequate response, and in adults with non-dialysis chronic kidney disease. Also treats iron deficiency in adults with NYHA class II/III heart failure to improve exercise capacity.